Clinical Trial Update: Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating early initiation of oral cyclosporine and eltrombopag in treatment-naive severe aplastic anemia; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Eltrombopag (eltrombopag)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Severe Aplastic Anemia | Phase 2 | Status: RECRUITING | Results posted: 2026-01-09